29 unchanged sentences
(the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.
−Removed: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the accompanying balance sheets of Inspire Medical Systems, Inc.
−Removed: (the Company) as of December 31, 2019 and 2018, the related statements of operations and comprehensive loss, stockholders' (deficit) equity and cash flows for each of the three years in the period ended December 31, 2019, and the related notes and our report dated February 25, 2020 expressed an unqualified opinion thereon.
+Added: We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the balance sheets of Inspire Medical Systems, Inc.
+Added: as of December 31, 2020 and 2019, the related statements of operations and comprehensive loss, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and our report dated February 23, 2021 expressed an unqualified opinion thereon.
Basis for Opinion
39 unchanged sentences
(1) The 2007 Plan terminated in accordance with its terms on November 28, 2017;
−Removed: In connection with our IPO, we adopted the 2018 Plan and will not make future grants or awards under the 2017 Plan.
−Removed: (2) Pursuant to the terms of the 2018 Plan, the number of shares of common stock available for issuance under the 2018 Plan automatically increases on each January 1, until and including January 1, 2028, by an amount equal to the lesser of (a) 739,631 shares, (b) 4% of the number of shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year, and (c) such smaller number of shares as is determined by our board of directors.
+Added: however, outstanding stock options may continue to be exercised in accordance with their terms.
+Added: In connection with our IPO, we adopted the 2018 Plan and do not make grants or awards under the 2017 Plan.
+Added: (2) Pursuant to the terms of the 2018 Plan, the number of shares of common stock available for issuance under the 2018 Plan automatically increases on each January 1, until and including January 1, 2028, by an amount equal to the lesser of (a) 739,631 shares, (b) 4% of the number of shares of common stock outstanding
+Added: (on an as-converted basis) on the last day of the immediately preceding fiscal year, and (c) such smaller number of shares as is determined by our board of directors.
(3) Pursuant to the terms of the 2018 ESPP Plan, the number of shares reserved under the 2018 ESPP Plan will automatically be supplemented each January 1, until and including January 1, 2028, by an amount of shares equal to the lesser of a) 184,908 shares, b) 1 % of the shares outstanding on the final day of the immediately preceding calendar year, and c) such smaller number of shares as the board of directors may determine.
26 unchanged sentences
S-1 333-224176 4.3 4/23/2018
−Removed: 4.4 Warrant to Purchase Series E Preferred Stock, dated June 27, 2014, issued by Inspire Medical Systems, Inc.
−Removed: to Silicon Valley Bank
−Removed: S-1 333-228668 4.4 12/4/2018
−Removed: 4.5 Form of Warrant to Purchase Series F Preferred Stock, dated February 24, 2017 or February 7, 2018, issued by Inspire Medical Systems, Inc.
−Removed: to Oxford Finance LLC, together with a schedule of material differences
−Removed: S-1 333-228668 4.5 12/4/2018
4.6 Description of Capital Stock
+Added: 10-K 001-38468 4.6 2/25/2020
10.1 Assignment and License Agreement, dated as of November 28, 2007, by and between Inspire Medical Systems, Inc.
10 unchanged sentences
S-1 333-224176 10.4 4/6/2018
−Removed: Number Description Form File No.
−Removed: Exhibit Filing
10.5 Second Amendment to the Loan and Security Agreement, dated as of March 27, 2019, by and between Inspire Medical Systems, Inc.
7 unchanged sentences
S-1 333-224176 10.8 4/6/2018
+Added: Number Description Form File No.
+Added: Exhibit Filing
10.9† Form of Incentive Stock Option Agreement pursuant to 2017 Stock Incentive Plan
8 unchanged sentences
S-1 333-224176 10.12 4/23/2018
+Added: 10.13† Form of Restricted Stock Unit Award Agreement under Inspire Medical Systems, Inc.
+Added: 2018 Incentive Award Plan
10.14† Inspire Medical Systems, Inc.
13 unchanged sentences
S-1 333-224176 10.21 4/23/2018
+Added: 10.19† Employment Agreement between the Company and Philip Ebeling
+Added: 8-K 001-38468 10.1 6/8/2020
+Added: 10.20† Employment Agreement between the Company and Bryan Phillips
10.21† Form of Indemnification Agreement between Inspire Medical Systems, Inc.
14 unchanged sentences
101.SCH Inline XBRL Taxonomy Extension Schema Document *
+Added: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document *
Number Description Form File No.
Exhibit Filing
−Removed: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document *
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
25 unchanged sentences
Marilyn Carlson Nelson
+Added: /s/ SHELLEY BROADER Director
+Added: Shelly Broader
ELLIS Director
1 unchanged sentence
Jerry Griffin, M.D.
−Removed: JAIN Director
−Removed: /s/ CHAU KHUONG Director
+Added: /s/ GEORGIA MELENIKIOTOU Director
+Added: Georgia Melenikiotou
/s/ SHAWN T MCCORMICK Director
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.